Company intelligence / Profile preview

Centipharm

Grasse, France

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Centipharm is a French contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and fine chemicals. Based in Grasse, the company provides services ranging from process development and pilot-scale production to full-scale industrial manufacturing. Centipharm operates as a subsidiary of the Axyntis Group, leveraging its expertise in complex organic synthesis to support global pharmaceutical and life science clients. The facility is GMP-certified and focuses on high-value small molecule chemistry. The company serves various therapeutic areas including oncology and central nervous system disorders by providing high-quality chemical intermediates.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Centipharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centipharm.

Explore the full profile